List of works - Rita Rizzi

A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome ⬇️

scientific article published on June 1, 2011

Autoimmune myelofibrosis: report of three cases and review of the literature

scientific article published on March 2004

Behçet’s disease: an immune-mediated vasculitis involving vessels of all sizes ⬇️

scientific article published on January 1, 1997

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients

scientific article published on 18 February 2014

Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature.

scientific article

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study

scientific article

Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction technique

scientific article published on 01 July 1991

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

scientific article

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis

scientific article published on 18 July 2018

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

scientific article published on 16 March 2007

Hepatitis C virus infection and mixed cryoglobulinemia: a striking association.

scientific article published in January 1993

Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide ⬇️

scientific article published on February 21, 2011

Malignant lymphoma involving a Warthin's tumor: a case with immunophenotypic and gene rearrangement analysis

scientific article published on 01 September 1990

Myeloma cells suppress osteoblasts through sclerostin secretion

scientific article published on 24 June 2011

Non-treatment-related chronic myeloid leukemia as a second malignancy

scientific article published on 01 February 2004

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

scientific article published on 30 March 2015

Pneumonia in Acute Leukemia Patients During Induction Therapy: Experience in a Single Institution

scientific article published on 01 January 2003

Schnitzler's syndrome: diagnosis, treatment, and follow-up

scientific article published on 09 March 2013

Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria

scientific article published on 9 July 2008

Sclerostin is overexpressed by plasma cells from multiple myeloma patients

scientific article

Soluble CD4 and commercial immunoglobulin

scientific article published on 01 June 1994

Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature

scientific article published on 07 May 2008

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

article

Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma

scientific article published on 25 March 2011

The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3

scientific article published on 01 March 2010

The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.

scientific article

Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia

scientific article published on 01 January 2003

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

scientific article published on 23 December 2014

List of works by Rita Rizzi

A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome ⬇️

Autoimmune myelofibrosis: report of three cases and review of the literature

Behçet’s disease: an immune-mediated vasculitis involving vessels of all sizes ⬇️

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients

Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature.

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study

Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction technique

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

Hepatitis C virus infection and mixed cryoglobulinemia: a striking association.

Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide ⬇️

Malignant lymphoma involving a Warthin's tumor: a case with immunophenotypic and gene rearrangement analysis

Myeloma cells suppress osteoblasts through sclerostin secretion

Non-treatment-related chronic myeloid leukemia as a second malignancy

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

Pneumonia in Acute Leukemia Patients During Induction Therapy: Experience in a Single Institution

Schnitzler's syndrome: diagnosis, treatment, and follow-up

Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria

Sclerostin is overexpressed by plasma cells from multiple myeloma patients

Soluble CD4 and commercial immunoglobulin

Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma

The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3

The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.

Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”